150 related articles for article (PubMed ID: 35720296)
1. Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
Furukawa M; Chan EG; Ryan JP; Hyzny EJ; Sacha LM; Coster JN; Pilewski JM; Lendermon EA; Kilaru SD; McDyer JF; Sanchez PG
Front Immunol; 2022; 13():864545. PubMed ID: 35720296
[TBL] [Abstract][Full Text] [Related]
2. Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
; Haynes R; Harden P; Judge P; Blackwell L; Emberson J; Landray MJ; Baigent C; Friend PJ
Lancet; 2014 Nov; 384(9955):1684-90. PubMed ID: 25078310
[TBL] [Abstract][Full Text] [Related]
3. Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis.
Li KHC; Ho JCS; Recaldin B; Gong M; Ho J; Li G; Liu T; Wu WKK; Wong MCS; Xia Y; Dong M; Tse G;
Transplant Proc; 2018 Dec; 50(10):3723-3731. PubMed ID: 30577263
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience.
Yakubu I; Ravichandran B; Sparkes T; Barth RN; Haririan A; Masters B
J Pharm Pract; 2021 Apr; 34(2):199-206. PubMed ID: 31315501
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
Furuya Y; Jayarajan SN; Taghavi S; Cordova FC; Patel N; Shiose A; Leotta E; Criner GJ; Guy TS; Wheatley GH; Kaiser LR; Toyoda Y
Am J Transplant; 2016 Aug; 16(8):2334-41. PubMed ID: 26833657
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of Basiliximab and Alemtuzumab induction therapies in blood type A2-to-B kidney transplantation: Impact on kidney function and de novo donor-specific HLA antibodies.
Hanouneh T; Attieh RM; Craver E; Jebrini A; Elrefaei M; Jarmi T
Transpl Immunol; 2023 Dec; 81():101958. PubMed ID: 37949378
[TBL] [Abstract][Full Text] [Related]
7. Alemtuzumab induction is associated with decreased hospitalization rates in pediatric kidney transplant: A UNOS data review for safety and outcomes with common induction regimens.
Aydin-Ghormoz E; Ortiz J; Koizumi N; Li MH; Faddoul G
Pediatr Transplant; 2024 Jun; 28(4):e14783. PubMed ID: 38767019
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic Infections After Induction With Alemtuzumab or Basiliximab: A 3-Year Kidney Transplantation Experience.
Florescu DF; Seaman JA; Kalil AC; Qiu F; Bremers D; Westphal SG
Transplant Proc; 2021 Apr; 53(3):1058-1063. PubMed ID: 32921434
[TBL] [Abstract][Full Text] [Related]
9. Alemtuzumab as compared to alternative contemporary induction regimens.
LaMattina JC; Mezrich JD; Hofmann RM; Foley DP; D'Alessandro AM; Sollinger HW; Pirsch JD
Transpl Int; 2012 May; 25(5):518-26. PubMed ID: 22394259
[TBL] [Abstract][Full Text] [Related]
10. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
[TBL] [Abstract][Full Text] [Related]
11. A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation.
Magliocca JF; Odorico JS; Pirsch JD; Becker YT; Knechtle SJ; Leverson GE; Sollinger HW
Am J Transplant; 2008 Aug; 8(8):1702-10. PubMed ID: 18694474
[TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab induction in renal transplantation.
Hanaway MJ; Woodle ES; Mulgaonkar S; Peddi VR; Kaufman DB; First MR; Croy R; Holman J;
N Engl J Med; 2011 May; 364(20):1909-19. PubMed ID: 21591943
[TBL] [Abstract][Full Text] [Related]
13. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
Pascual J; Pirsch JD; Odorico JS; Torrealba JR; Djamali A; Becker YT; Voss B; Leverson GE; Knechtle SJ; Sollinger HW; Samaniego-Picota MD
Transplantation; 2009 Jan; 87(1):125-32. PubMed ID: 19136902
[TBL] [Abstract][Full Text] [Related]
14. A comparison of three induction therapies on patients with delayed graft function after kidney transplantation.
Umber A; Killackey M; Paramesh A; Liu Y; Qin H; Atiq M; Lee B; Alper AB; Simon E; Buell J; Zhang R
J Nephrol; 2017 Apr; 30(2):289-295. PubMed ID: 27062485
[TBL] [Abstract][Full Text] [Related]
15. Basiliximab is associated with a lower incidence of De novo donor-specific HLA antibodies in kidney transplant recipients: A single-center experience.
Jarmi T; Abdelmoneim Y; Li Z; Jebrini A; Elrefaei M
Transpl Immunol; 2023 Apr; 77():101778. PubMed ID: 36584928
[TBL] [Abstract][Full Text] [Related]
16. Induction therapy in lung transplantation: A contemporary analysis of trends and outcomes.
Shagabayeva L; Osho AA; Moonsamy P; Mohan N; Li SS; Wolfe S; Langer NB; Funamoto M; Villavicencio MA
Clin Transplant; 2022 Nov; 36(11):e14782. PubMed ID: 35848518
[TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial.
Welberry Smith MP; Cherukuri A; Newstead CG; Lewington AJ; Ahmad N; Menon K; Pollard SG; Prasad P; Tibble S; Giddings E; Baker RJ
Transplantation; 2013 Dec; 96(12):1082-8. PubMed ID: 24056618
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Alemtuzumab Versus Basiliximab Induction: A Retrospective Cohort Study in Lung Transplant Recipients.
Whited LK; Latran MJ; Hashmi ZA; Wang IW; Wozniak TC; Duncan MD; Roe DW; Baz MA; Hage CA
Transplantation; 2015 Oct; 99(10):2190-5. PubMed ID: 25769073
[TBL] [Abstract][Full Text] [Related]
19. Antibody induction therapy for lung transplant recipients.
Penninga L; Møller CH; Penninga EI; Iversen M; Gluud C; Steinbrüchel DA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD008927. PubMed ID: 24282128
[TBL] [Abstract][Full Text] [Related]
20. Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.
Koyawala N; Silber JH; Rosenbaum PR; Wang W; Hill AS; Reiter JG; Niknam BA; Even-Shoshan O; Bloom RD; Sawinski D; Nazarian S; Trofe-Clark J; Lim MA; Schold JD; Reese PP
J Am Soc Nephrol; 2017 Jul; 28(7):2188-2200. PubMed ID: 28320767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
